Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Morgan

Showing results (31-40 of 247) with videos related to

Pageof 25
Sort By:
Molecular Immunology|March 4, 2000
Complement activation and inhibition in experimental models of arthritisS M Linton, B P Morgan
Biochemistry|May 10, 2000
Identification of mutations in rat CD59 that increase the complement regulatory activityS J Hinchliffe, B P Morgan
Nature|September 12, 1985
Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attackA K Campbell, B P Morgan
Clinical and Experimental Immunology|November 11, 1999
Properdin deficiency and meningococcal disease--identifying those most at riskS M Linton, B P Morgan
Journal of Neuroimmunology|November 1, 1993
Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysisS J Piddlesden, B P Morgan
Biochemical Society Transactions|August 1, 1990
Non-lethal doses of antibody and complement stimulate release of prostaglandin E2 from human amniotic cells in vitroI A Rooney, B P Morgan
Immunology Today|September 1, 1991
Complement deficiency and diseaseB P Morgan, M J Walport
The Journal of Infectious Diseases|November 17, 1998
Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblastsO B Spiller, B P Morgan
The Medical Journal of Australia|December 1, 1979
Bowel preparation with mannitolG L Newstead, B P Morgan
Immunology|November 1, 1990
Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteinsI A Rooney, B P Morgan
Pageof 25

Showing results (31-40 of 247) with videos related to

Sort By:
Pageof 25
Molecular Immunology|March 4, 2000
Complement activation and inhibition in experimental models of arthritisS M Linton, B P Morgan
Biochemistry|May 10, 2000
Identification of mutations in rat CD59 that increase the complement regulatory activityS J Hinchliffe, B P Morgan
Nature|September 12, 1985
Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attackA K Campbell, B P Morgan
Clinical and Experimental Immunology|November 11, 1999
Properdin deficiency and meningococcal disease--identifying those most at riskS M Linton, B P Morgan
Journal of Neuroimmunology|November 1, 1993
Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysisS J Piddlesden, B P Morgan
Biochemical Society Transactions|August 1, 1990
Non-lethal doses of antibody and complement stimulate release of prostaglandin E2 from human amniotic cells in vitroI A Rooney, B P Morgan
Immunology Today|September 1, 1991
Complement deficiency and diseaseB P Morgan, M J Walport
The Journal of Infectious Diseases|November 17, 1998
Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblastsO B Spiller, B P Morgan
The Medical Journal of Australia|December 1, 1979
Bowel preparation with mannitolG L Newstead, B P Morgan
Immunology|November 1, 1990
Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteinsI A Rooney, B P Morgan
Pageof 25